AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Phase I/II results in AIDS-related lymphoma. (Oncolysin B)
Data from a completed Phase I/II study of ImmunoGen Inc.'s, Cambridge, Massachusetts, Oncolysin B, show that it is well tolerated when given in combination with conventional chemotherapy to patients newly diagnosed with AIDS-related lymphoma.
These results were reported at the American Society of Hematology (ASH) Thirty-Sixth Annual Meeting in Nashville, Tennessee.
Encouraged by the Phase I/II data, and in anticipation of a pivotal study using Oncolysin B in AIDS-related lymphoma, ImmunoGen has now started a pilot study to further examine the role of the drug in this setting. These studies in AIDS-lymphoma patients are in addition to other open and completed …
-
- Oncolysin B enters human clinical trials for the treatment of AIDS-related...
-
Newspaper article from: AIDS Weekly
October 7, 1991
700+ words
-
- Phase I/II trials data. (of ImmunoGen's Oncolysin B)
-
Newspaper article from: AIDS Weekly
May 30, 1994
700+ words
-
- Blocked ricin technology increases potency of cancer therapeutics 1,000-fold....
-
Newspaper article from: AIDS Weekly
December 23, 1991
700+ words
